Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
VREX 
Varex Imaging Corp (VREX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: VREX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $16.6
1 Year Target Price $16.6
| 3 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 12.14% | Avg. Invested days 49 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 356.18M USD | Price to earnings Ratio - | 1Y Target Price 16.6 |
Price to earnings Ratio - | 1Y Target Price 16.6 | ||
Volume (30-day avg) 5 | Beta 0.67 | 52 Weeks Range 6.76 - 16.93 | Updated Date 06/30/2025 |
52 Weeks Range 6.76 - 16.93 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.03 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -5.08% | Operating Margin (TTM) 10.38% |
Management Effectiveness
Return on Assets (TTM) 2.56% | Return on Equity (TTM) -7.17% |
Valuation
Trailing PE - | Forward PE 18.25 | Enterprise Value 723880089 | Price to Sales(TTM) 0.43 |
Enterprise Value 723880089 | Price to Sales(TTM) 0.43 | ||
Enterprise Value to Revenue 0.87 | Enterprise Value to EBITDA 9.8 | Shares Outstanding 41512800 | Shares Floating 40958840 |
Shares Outstanding 41512800 | Shares Floating 40958840 | ||
Percent Insiders 1.68 | Percent Institutions 95.67 |
Analyst Ratings
Rating 3 | Target Price 16.6 | Buy 1 | Strong Buy 3 |
Buy 1 | Strong Buy 3 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Varex Imaging Corp
Company Overview
History and Background
Varex Imaging Corp. was formed in 2017 as a spin-off from Varian Medical Systems (now part of Siemens Healthineers). It inherited Varian's imaging components business, building upon decades of experience in X-ray imaging technology.
Core Business Areas
- Medical: Manufactures and sells X-ray tubes, digital detectors, and other imaging components for medical diagnostic applications (radiography, fluoroscopy, computed tomography, mammography, and radiation therapy).
- Industrial: Provides X-ray imaging solutions for industrial applications, including non-destructive testing, security screening, and cargo inspection.
- Security: Offers X-ray imaging products and services for security applications like airport screening, border security, and critical infrastructure protection.
Leadership and Structure
Sunny Sanyal serves as the Chief Executive Officer. The company operates with a functional organizational structure, dividing responsibilities across departments like sales, marketing, engineering, and manufacturing.
Top Products and Market Share
Key Offerings
- X-ray Tubes: Varex is a leading supplier of X-ray tubes used in a wide range of medical and industrial imaging systems. Competitors include Dunlee (Philips) and Toshiba Electron Tubes. Market share data is difficult to pinpoint exactly but Varex is estimated to have a significant portion of the global market.
- Digital Detectors: Varex produces digital detectors that convert X-rays into digital images. Competitors include Canon Medical, Trixell (Thales), and PerkinElmer. Market share data is difficult to pinpoint exactly but Varex is estimated to have a significant portion of the global market.
- Software and Workstations: Software and workstations that support the generation and optimization of the imaging. Competitors are other software companies. Market share data is difficult to pinpoint exactly.
Market Dynamics
Industry Overview
The medical and industrial X-ray imaging market is driven by factors like aging populations, increasing demand for diagnostic imaging, technological advancements (e.g., digital detectors), and stringent security regulations.
Positioning
Varex is a key player in the X-ray imaging components market, known for its broad product portfolio, technological expertise, and global presence. It holds a strong position in both medical and industrial applications.
Total Addressable Market (TAM)
The global X-ray imaging market is estimated to be worth billions of dollars annually. Varex is well-positioned to capture a significant portion of this TAM by providing essential components and solutions to OEMs and end-users.
Upturn SWOT Analysis
Strengths
- Broad product portfolio
- Established market position
- Technological expertise
- Global distribution network
- Strong customer relationships
Weaknesses
- Dependence on OEM customers
- Exposure to cyclical demand
- Potential impact of technological obsolescence
- Reliance on a few key suppliers
- Susceptibility to regulatory changes
Opportunities
- Growth in emerging markets
- Expansion into new applications (e.g., AI-powered imaging)
- Acquisitions of complementary businesses
- Development of next-generation imaging technologies
- Increased demand for security screening
Threats
- Intense competition
- Technological disruption
- Economic downturns
- Changes in reimbursement policies
- Geopolitical instability
Competitors and Market Share
Key Competitors
- SI
- PKI
- TDSCY
Competitive Landscape
Varex competes on the basis of product performance, reliability, customer service, and price. It holds an advantage in terms of its broad product portfolio and established market position.
Major Acquisitions
Direct Conversion
- Year: 2017
- Acquisition Price (USD millions): 80
- Strategic Rationale: Expanded Varexu2019s capabilities in digital detector technology.
Growth Trajectory and Initiatives
Historical Growth: Varex's growth has been influenced by factors such as market demand, technological innovation, and strategic acquisitions. Recent growth has also been affected by global economic factors.
Future Projections: Future growth is expected to be driven by increasing demand for medical imaging, expansion in emerging markets, and the development of new applications.
Recent Initiatives: Recent initiatives include investments in R&D, expansion of its product portfolio, and strategic partnerships to expand its market reach.
Summary
Varex Imaging Corp. is a significant player in the medical and industrial imaging components market. It has a broad product portfolio and an established market position, making it a reasonably strong player. However, it faces challenges from competitors and potential technological disruptions. Continued innovation and strategic initiatives will be key to maintaining its competitive edge and achieving future growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
- Press releases
Disclaimers:
The information provided is for general informational purposes only and should not be construed as financial advice. Market share data are estimates and may vary. Investment decisions should be based on thorough research and consultation with a financial professional.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Varex Imaging Corp
Exchange NASDAQ | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 2017-01-20 | President, CEO & Director Mr. Sunny S. Sanyal | ||
Sector Healthcare | Industry Medical Devices | Full time employees 2300 | Website https://www.vareximaging.com |
Full time employees 2300 | Website https://www.vareximaging.com | ||
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.